| Peer-Reviewed

General Approach for Isolation of Immunoglobulins Fragments with the Core Hinge

Received: 6 October 2014    Accepted: 1 November 2014    Published: 18 November 2014
Views:       Downloads:
Abstract

The original limited proteolysis approach was proposed for large (multidomain) proteins with post-translational modifications for obtaining of their novel fragments. It was realized for human immunoglobulins representing two subclasses IgG2 and IgG3. This approach was based on two techniques: masking of protein regions which are normally susceptible to proteolytic enzymes and increasing the possibility of proteolysis for sites which are not ordinarily accessible to these enzymes. The masking of immunoglobulin part which is sensitive to proteolysis was performed by Fab fragments (Fv subfragments) of antibodies and the increase of lability of stable regions was realized by pH change and mild reduction of disulfide bonds.

Published in International Journal of Immunology (Volume 2, Issue 3)
DOI 10.11648/j.iji.20140203.11
Page(s) 16-23
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Limited Proteolysis, Immunoglobulin, Hinge, Fc Fragment, Facb Fragment

References
[1] R.R .Porter, “The hydrolysis of rabbit y-globulin and antibodies with crystalline papain,” Biochem. J., vol.73, pp. 119–126, 1959.
[2] D.R. Burton, and J.M. Woof, “Human antibody effector function,” Adv. Immunol., vol.51, pp.1-84, 1992.
[3] H.W. Jr. Schroeder, and L. Cavacini, “Structure and function of immunoglobulins,” J. Allergy Clin. Immunol., vol. 125, pp. 41-52, 2-10.
[4] A.N. Weir, A. Nesbitt, A.P. Chapman, A.G. Popplewell, P. Antoniw, and A.D. Lawson, “Formatting antibody fragments to mediate specific therapeutic functions,” Biochem. Soc. Trans., vol. 30, pp. 512-516, 2002.E.C. Franklin, “Structural units of human 7S gamma globulin,” J. Clin. Invest., vol.39, pp. 1933-1941, 1960.
[5] G.E. Connell, and R.R. Porter, “A new enzymic fragment (Facb) of rabbit immunoglobulin G,” Biochem. J., vol.124, p. 53P, 1971.
[6] M. Colomb, and R.R. Porter, “Characterization of a plasmin-digest fragment of rabbit immunoglobulin gamma that binds antigen and complement,” Biochem. J., vol.145, pp. 177-183, 1975.
[7] V.M. Tischenko, “Metastable state of the Fc fragment,” J. Therm. Anal. Calorimetry, vol.62, pp. 6368, 2000.
[8] V.M. Tischenko, and V.P. Zav’yalov, “Long-term metastable conformation of human Fc gamma subunit,” Immunol. Lett., vol.84, pp. 241-245, 2002.
[9] V.P. Zav’yalov, and V.M. Tishchenko, “Mechanisms of generation of antibody diversity as a cause for natural selection homeothermic animals in the process of evolution,” Scand. J. Immunol., vol.33, pp. 755-762, 1991.
[10] V.M. Tischenko, V.M. Abramov, and V.P. Zav’yalov, “Investigation of the cooperative structure of Fc fragments from myeloma immunoglobulin G,” Biochemistry, vol.37, pp. 5576-5581, 1998.
[11] M.A. Timchenko, and V.M. Tischenko, “The destabilization of CH2 domains in intact IgG2 is accompanied by reduced ability to inhibit complement system factor C1,” Biochemistry (Mosc.), vol.78, pp. 759-766, 2013.
[12] C.R. Caffrey, S. Scory, and D. Steverding, “Cysteine proteinases of trypanosome parasites: novel targets for chemotherapy,” Curr. Drug. Targets., vol.1, pp. 155-162, 2000.
[13] J.J. Cazzulo, V. Stoka, and V. Turk, “The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease,” Curr. Pharm. Des., vol.7, pp. 1143-1156, 2001.
[14] 14. J.J. Cazzulo, “Proteinases of Trypanosoma cruzi: patential targets for the chemotherapy of Changas desease,” Curr. Top. Med. Chem., vol.2, pp. 1261-71, 2002.
[15] 15. P. Berasain, C. Carmona, B. Frangione, J.J. Cazzulo, and F. Goñi, “Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi,” Mol. Biochem. Parasitol., vol.130, pp. 23-29, 2003.
[16] . R. Chen, “Bacterial expression systems for recombinant protein production: E. coli and beyond,” Biotechnol. Adv., vol.30, pp. 1102-1107, 2012.
[17] D. Mattanovich, P. Branduardi, L. Dato, B. Gasser, M. Sauer, and D. Porro, “Recombinant protein production in yeasts,” Methods Mol. Biol., vol.824, pp. 329-358, 2012.
[18] T. Burnouf, “Recombinant plasma proteins,” Vox. Sang., vol.100, pp. 68-83, 2011.
[19] S. Huck, P. Fort, D.H. Crawford, M.P. Lefranc, and G. Lefranc, “Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: comparison with the other human C gamma genes,” Nucleic Acids Res., vol.14, pp. 1779-1789, 1986).
[20] I.R. Correia, “Stability of IgG isotypes in serum,” MAbs., vol.2, pp. 221-232, 2010.
[21] I. Ritamo, M. Cloutier, L. Valmu, S. Neron, and J. Räbinä, “Comparison of the glycosylation of in vitro generated polyclonal human IgG and therapeutic immunoglobulins,” Mol. Immunol., vol.57, pp. 255-262, 2014.
[22] A.E. Hills, A. Patel, P. Boyd, and D.C. James, “Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells,” Biotechnol. Bioeng, vol.75, pp. 239-251, 2001.
[23] I. Chantret, T. Duprè, C. Delenda, S. Bucher, J. Dancourt, A. Barnier, A. Charollais, D. Heron, B. Bader-Meunier, O. Danos, N. Seta, G. Durand, R. Oriol, P. Codogno, and S.E. Moore, “Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase,” J. Biol. Chem., vol.277, pp. 25815-25822, 2002.
[24] C. Thiel, M. Schwarz, M. Hasilik, U. Grieben, F. Hanefeld, L. Lehle, K. von Figura, and C. Körner, “Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation type Ig,” Biochem. J., vol.367, pp. 195-201, 2002.
[25] C. Fagioli, and R. Sitia, “Glycoprotein quality control in the endoplasmic reticulum. Mannose trimming by endoplasmic reticulum mannosidase I times the proteasomal degradation of unassembled immunoglobulin subunits,” J. Biol. Chem., vol.276, pp. 12885-12892, 2001.
[26] K. Ko, Y. Tekoah, P.M. Rudd, D.J. Harvey, R.A. Dwek, S. Spitsin, C.A. Hanlon, C. Rupprecht, B. Dietzschold, M. Golovkin, and H. Koprowski, “Function and glycosylation of plant-derived antiviral monoclonal antibody,” Proc. Natl. Acad. Sci. U S A, vol.100, pp. 8013-8018, 2003.
[27] F.A. Gala, and S.L. Morrison, “V region carbohydrate and antibody expression,” J. Immunol., vol.172, pp. 5489-5494, 2004.
[28] J. Eder, M. Rheinnecker, and A.R. Fersht, “Folding of subtilisin BPN': role of the pro-sequence,” J. Mol. Biol., vol.233, pp. 293-304, 1993.
[29] J.L. Sohl, S.S. Jaswal, and D.A. Agard, “Unfolded conformations of alpha-lytic protease are more stable than its native state,” Nature, vol.395, pp. 817-819, 1998.
[30] J.C. Whisstock, and S.P. Bottomley, “Molecular gymnastics: serpin structure, folding and misfolding,” Curr. Opin. Struct. Biol., vol.16, pp. 761-768, 2006.
[31] T.O. Baldwin, J.A. Christopher, F.M. Raushel, J.F. Sinclair, M.M. Ziegler, A.J. Fisher, and I. Rayment, “Structure of bacterial luciferase,” Curr. Opin. Struct. Biol., vol.5, pp. 798-809, 1995.
[32] A.I. Denesiuk, V.M. Tishchenko, V.M. Abramov, and V.P. Zav’yalov, “Theoretical and experimental studies on the conformation of the hinge region in human immunoglobulin subclasses,” Mol. Biol. (Mosk.), vol.17, pp. 1257-1266, 1983.
[33] K.W. Hedlund, R.Jr. Wistar, and D. Nichelson, “The identification of the subclasses of human IgG by analytical isotachophoresis,” J. Immunol. Methods, vol.25, pp. 43-48, 1979.
[34] R.G. Navalkar, M. Norlin, and O. Ouchterlony, “Characterization of leprosy sera with various mycobacterial antigens using double diffusion-in-gel analysis-II,” Int. Arch. Allergy Appl. Immunol, vol.28, pp. 250-260, 1965.
[35] K. Weber, and M. Osborn, “The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis,” J. Biol. Chem., vol.244, pp. 4406-4412, 1969.
[36] B. Frangione, E.C. Franklin, H.H. Fudenberg, and M.E. Koshland, “Structural studies of human gamma-G-myeloma proteins of different antigenic subgroups and genetic specificities,” J. Exp. Med., vol.124, pp. 715-732, 1966.
[37] R.A. Vogt, and T.E. Michaelsen, “Enzymatic fragmentation of an unusual human IgG2 (Kva) myeloma protein,” Scand. J. Immunol., vol.26, pp. 59-69, 1987.
[38] J.R. Ellerson, D. Yasmeen, R.H. Painter, and K.J. Dorrington, “A fragment corresponding to the C(H)2 region of immunoglobulin G (IgG) with complement fixing activity,” FEBS Lett., vol.24, pp. 318-322, 1972.
[39] J.R. Ellerson, D. Yasmeen, R.H. Painter, and K.J. Dorrington, “Structure and function of immunoglobulin domains. III. Isolation and characterization of a fragment corresponding to the Cgamma2 homology region of human immunoglobin G1,” J. Immunol., vol.116, pp. 510-517, 1976.
[40] V.M. Tishchenko, V.S. Khristoforov, and O.P. Blizniukov, “Thermodynamic and hydrodynamic study of Bence-Jones proteins,” Mol. Biol. (Mosk.), vol.43, pp. 148-156, 2009.
[41] V.M. Tishchenko, “Effect of interdomain interaction on amyloidogenic properties of Bence-Jones proteins,” Mol. Biol. (Mosk.), vol.45, pp. 1055-1064, 2011.
[42] M.W. Turner, H.H. Bennich, and J.B. Natvig, “Pepsin digestion of human G-myeloma proteins of different subclasses. I. The characteristic features of pepsin cleavage as a function of time,” Clin. Exp. Immunol., vol.7, pp. 603-625, 1970.
[43] V.M. Tishchenko, “The hinge region of human IgG3 is rod-like under acidic pH condition,” Mol. Biol. (Mosk.), vol.34, pp. 95-100, 2000.
[44] V.M. Tishchenko, “The unusual thermodynamic properties of compact forms pFh fragments (hinge region) IgG3 Kuc and Sur,” Mol. Biol. (Mosk.), vol.45, pp. 1065-1072, 2011.
[45] E.A. Kabat, T.T. Wu, M. Reid-Miller, H.M. Perry, and K. Gottesman, “Sequences of Proteins of Immunological Interest,” 4th ed., National Institutes of Health, Bethesda, Md., 1987.
[46] B. Sjoberg, E. Rosenqvist, T. Michaelsen, S. Pap, and R. Osterberg, “The solution shapes of IgG3 immunoglobulin and its Fch and Fc fragments. A small-angle X-ray scattering study,” Biochim. Biophys. Acta, vol.625, pp. 10-17, 1980.
[47] T.E. Michaelsen, B. Frangione, and E.C. Franklin, “Primary structure of the “hinge” region of human IgG3. Probable quadruplication of a 15-amino acid residue basic unit,” J. Biol. Chem., vol.252, pp. 883-889, 1977.
[48] V.M. Tischenko, “Effect of hinge region state on interaction of human IgG3 with complement system,” Biochemistry (Mosc.), vol.66, pp. 1352-1355, 2001.
[49] O.P. Bliznyukov, L.D. Kozmin, L.L. Vysotskaya, A.K. Golenkov, V.M. Tishchenko, M.P. Samoylovich, and V.B. Klimovich, “Human immunoglobulin light chains lambda form amyloid fibrils and granular aggregates in solution,” Biochemistry (Mosc.), vol.70, pp. 458-466, 2005.
[50] D.A. Yphantis, “Equilibrium ultracentrifugation of dilute solutions,” Biochemistry, vol.3, pp. 297-317, 1964.
[51] K.E. Van Holde, and R.L. Baldwin, “New approach for molecular weight determination,” J. Phys. Chem., vol.62, pp. 734-743, 1958.
[52] P.L. Privalov, and S.A. Potekhin, “Scanning microcalorimetry in studying temperature-induced changes in proteins,” Meth. Enzymol., vol.131, pp. 4-51, 1986.
[53] C. Renneboog-, “Conformational study of the human immunoglobulin G1 hinge peptide,” J. Mol. Biol., vol.64, pp. 221-236, 1972.
[54] P.L. Privalov, E.I. Tiktopulo, and V.M. Tischenko, “Stability and mobility of the collagen structure,” J. Mol. Biol., vol. 127, pp. 203-216, 1979.
[55] V.M. Tischenko, A.M. Ichtchenko, C.V. Andreyev, and A.V. Kajava, “Thermodynamic studies of the collagen-like region of human subcomponent C1q. A water-containing structural model,” J. Mol. Biol., vol.234, pp. 654-660, 1993.
[56] S.A. Potekhin, and P.L. Privalov, “Co-operative blocks in tropomyosin,” J. Mol. Biol., vol.159, pp. 519-535, 1982.
[57] М. Marquart, J. Deisenhofer, R. Huber, and W. Palm, “Crystallographic refinement and atomic models of intact molecule Kol and its antigen-binding fragment at 3.0 Å and 1.9 Å resolution,” J. Mol. Biol., vol.141, pp. 369-391, 1980.
[58] L.J. Harris, S.B. Larson, K.W. Hasel, J. Day, A. Greenwood, and A. McPherson, “The three-dimensional structure of an intact monoclonal antibody for canine lymphoma,” Nature, vol.360, pp. 369-372, 1992.
[59] L.J. Harris, E. Skaletsky, and A. McPherson, “Crystallographic structure of an intact IgG1 monoclonal antibody,” J. Mol. Biol., vol.275, pp. 861-872, 1998
[60] S. Ryazantsev, V. Tishchenko, V. Vasiliev, V. Zav'yalov, and V. Abramov, “Structure of human myeloma IgG3 Kuc,” Eur. J. Biochem., vol.190, pp. 393-399, 1990.
[61] V.M. Tishchenko, “Hydration of the compact and extended forms of pFh fragments from IgG3 Kuc and Sur,” Biofizika, vol.56, pp. 5-6, 2011.
[62] V.M. Tischenko, and V.P. Zav’yalov, “Core hinge of human immunoglobulin G3 as a system of four independent co-operative blocks,” Immunol. Lett., vol.86, pp. 281-285, 2003.
[63] V.M. Tischenko, G.A. Zav'yalova, and V.P. Zav’yalov, “Folding of the human immunoglobulin G3 Kus core hinge into the thirteenth globular domain,” Immunol. Lett., vol.90, pp. 43-47, 2003.
[64] C. Milstein, and B. Frangione, “Disulphide bridges of the heavy chain of human immunoglobulin G2,” Biochem. J., vol.121, pp. 217-225, 1971.
[65] J.L. Dangl, T.G. Wensel, S.L. Morrison, L. Stryer, L.A. Herzenberg, and V.T. Oi, “Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies,” EMBO J., vol.7, pp. 1989-1994, 1988.
[66] R.F. Latypov, S. Hogan, H. Lau, H. Gadgil, and D. Liu, “Elucidation of acid-induced unfolding and aggregation of human immunoglobulin IgG1 and IgG2 Fc,” J. Biol. Chem., vol.287, pp. 1381-1396, 2012.
[67] A.C. Wang, and H.H. Fudenberg, “Fc and Fab fragments from IgG2 human immunoglobulins characterized,” Nature New Biol., vol.240, pp. 24-26, 1972.
[68] V.M. Tischenko, V.P. Zav’yalov, G.A. Medgyesi, S.A. Potekhin, and P.L. Privalov, “A thermodynamic study of cooperative structure in rabbit immunoglobulin G,” Eur J. Biochem., vol.126, pp. 517521, 1982.
[69] V.M. Tishchenko, L. Lund, M. Goodall, and R. Jefferis, “Cooperative structures within glycosylated and aglycosylated mouse IgG2b,” in Labbury J.E, Chowhry BZ, Eds., Biocalorimetry, Applications of calorimetry in the biological sciences. Wiley, London, 1998, pp 267-275.
[70] V.M. Tishchenko, “Correlation between macro- and micro-stability СН2 domains of human IgG2 and their biological activity. I. Analysis the calorimetric and optical melting curves,” Mol. Biol. (Mosk.), vol.48, pp. 480-490, 2014.
[71] R. Pumphrey, “Structure human IgG subclasses,” Immunol. Today, vol.7, pp. 174-178, 1986.
[72] A. Molla, T. Kagimoto, and H. Maeda, “Cleavage of immunoglobulin G (IgG) and IgA around the hinge region by proteases from Serratia marcescens,” Infect. Immun., vol.56, pp. 916-920, 1988.
[73] M.A. Kerr, L.M. Loomes, and B.W. Senior, “Cleavage of IgG and IgA in vitro and in vivo by the urinary tract pathogen Proteus mirabilis,” Adv. Exp. Med. Biol. Vol.371A, pp. 609-611, 1995.
[74] E.A. Padlan, “Fc receptors and the action of antibodies: X-ray diffraction studies of antibody constant regions,” in Metzger H, Eds., American Society for Microbiology, Washington D.C., 1990, pp 12-30.
[75] V.M. Tischenko, “Metastable state of the Fc fragment from myeloma IgG3,” Mol. Biol. (Mosk.), vol.48, 2014, in press.
[76] V.M. Tishchenko, “The properties of Fc fragment IgG3 PET with compact hinge region,” Biochemistry (Mosc.), vol.79, 2014, in press.
[77] B. Sjoberg, E. Rosenqvist, T. Michaelsen, S. Pap, and R. Osterberg, “The solution shapes of IgG3 immunoglobulin and its Fch and Fc fragments. A small-angle X-ray scattering study,” Biochim. Biophys. Acta, vol.625, pp. 10-17, 1980.
[78] L. Gregory, K.G. Davis, B. Sheth, J. Boyd, R. Jefferis, C. Nave, and D.B. Bartom, “The solution conformations of the subclasses of human IgG deduced from sedimentation and small angle X-ray scattering studies,” Mol. Immunol., vol.24, pp. 821-829, 1987.
[79] V.M. Tishchenko, “Obtaining of complement system factors C1q with one or two “heads”,” Mol. Biol. (Mosk.), 2014, in press
Cite This Article
  • APA Style

    Maria Timchenko, Vladimir Tischenko. (2014). General Approach for Isolation of Immunoglobulins Fragments with the Core Hinge. International Journal of Immunology, 2(3), 16-23. https://doi.org/10.11648/j.iji.20140203.11

    Copy | Download

    ACS Style

    Maria Timchenko; Vladimir Tischenko. General Approach for Isolation of Immunoglobulins Fragments with the Core Hinge. Int. J. Immunol. 2014, 2(3), 16-23. doi: 10.11648/j.iji.20140203.11

    Copy | Download

    AMA Style

    Maria Timchenko, Vladimir Tischenko. General Approach for Isolation of Immunoglobulins Fragments with the Core Hinge. Int J Immunol. 2014;2(3):16-23. doi: 10.11648/j.iji.20140203.11

    Copy | Download

  • @article{10.11648/j.iji.20140203.11,
      author = {Maria Timchenko and Vladimir Tischenko},
      title = {General Approach for Isolation of Immunoglobulins Fragments with the Core Hinge},
      journal = {International Journal of Immunology},
      volume = {2},
      number = {3},
      pages = {16-23},
      doi = {10.11648/j.iji.20140203.11},
      url = {https://doi.org/10.11648/j.iji.20140203.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.iji.20140203.11},
      abstract = {The original limited proteolysis approach was proposed for large (multidomain) proteins with post-translational modifications for obtaining of their novel fragments. It was realized for human immunoglobulins representing two subclasses IgG2 and IgG3. This approach was based on two techniques: masking of protein regions which are normally susceptible to proteolytic enzymes and increasing the possibility of proteolysis for sites which are not ordinarily accessible to these enzymes. The masking of immunoglobulin part which is sensitive to proteolysis was performed by Fab fragments (Fv subfragments) of antibodies and the increase of lability of stable regions was realized by pH change and mild reduction of disulfide bonds.},
     year = {2014}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - General Approach for Isolation of Immunoglobulins Fragments with the Core Hinge
    AU  - Maria Timchenko
    AU  - Vladimir Tischenko
    Y1  - 2014/11/18
    PY  - 2014
    N1  - https://doi.org/10.11648/j.iji.20140203.11
    DO  - 10.11648/j.iji.20140203.11
    T2  - International Journal of Immunology
    JF  - International Journal of Immunology
    JO  - International Journal of Immunology
    SP  - 16
    EP  - 23
    PB  - Science Publishing Group
    SN  - 2329-1753
    UR  - https://doi.org/10.11648/j.iji.20140203.11
    AB  - The original limited proteolysis approach was proposed for large (multidomain) proteins with post-translational modifications for obtaining of their novel fragments. It was realized for human immunoglobulins representing two subclasses IgG2 and IgG3. This approach was based on two techniques: masking of protein regions which are normally susceptible to proteolytic enzymes and increasing the possibility of proteolysis for sites which are not ordinarily accessible to these enzymes. The masking of immunoglobulin part which is sensitive to proteolysis was performed by Fab fragments (Fv subfragments) of antibodies and the increase of lability of stable regions was realized by pH change and mild reduction of disulfide bonds.
    VL  - 2
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Laboratory of NMR of Biosystems, Institute of Theoretical and Experimental Biophysics RAS, Pushchino, Russia

  • Laboratory of NMR of Biosystems, Institute of Theoretical and Experimental Biophysics RAS, Pushchino, Russia

  • Sections